PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS

Cardiovascular diseases (CVDs) are the leading cause of disability and mortality worldwide. Increased thrombosis is the trigger point for the development of various CVDs and their complications, and therefore, therapy with P2Y12-receptor inhibitors is always pathogenetically justified and vital. How...

Full description

Bibliographic Details
Main Authors: B. I. Kantemirova, E. A. Orlova, O. S. Polunina, E. N. Chernysheva, M. A. Abdullaev, D. A. Sychev
Format: Article
Language:Russian
Published: Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University 2021-05-01
Series:Farmaciâ i Farmakologiâ (Pâtigorsk)
Subjects:
antiplatelet agents
clopidogrel
pharmacogenetics
ethnic groups
resistance to antiplatelet therapy
Online Access:https://www.pharmpharm.ru/jour/article/view/768

Similar Items

Similar Items